Cartesian Therapeutics Inc (RNAC)
$6.49 -3.85% Close Oct 30, 2026 Live
Cartesian Therapeutics stock today
Cartesian Therapeutics closed at $6.49 on October 30, 2026, down 3.85% on the day. Over the past year it returned -20.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $191 million.
$6.00$8.00$10.00
NovJan 2026MarMayJulSep
| Period | RNAC | S&P 500 (SPY) |
|---|---|---|
| 1 month | -10.0% | -0.9% |
| 3 months | -16.0% | +2.1% |
| Year to date | -10.0% | +11.7% |
| 1 year | -20.0% | +12.4% |
| 3 years | -82.8% | +88.5% |
| 5 years | -94.0% | +76.0% |
Key statistics
- Market value
- $191M
- Price / sales
- 129.3
- 52-week range
- $5.84 to $10.59
- Next report
- Nov 5, 2026 (estimated)
About Cartesian Therapeutics
Biopharmaceutical company developing cellular immunotherapies for cancer and autoimmune diseases.
Sector: Health Care
More on Cartesian Therapeutics
- Financials: revenue, earnings and segmentsRevenue -93% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $13.04 today
No forecast, no recommendation. This page describes Cartesian Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.